Kyrgyzstan Pharmaceuticals & Healthcare Q2 2020
Commercial opportunities for innovative drugmakers are severely restricted in Kyrgyzstan, which remains viewed as oneof the least attractive markets both regional and globally. Low per capita spending on healthcare makes for a limited demand forpatented medicines. While the demographic and epidemiological trends are largely positive, market access for multinationalcompany products is constrained by the presence of counterfeit medicines and challenges in supply and distribution across thecountry.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook